Studies performed in adults with long-standing obesity suggest a reduced lipolytic sensitivity to catecholamines in subcutaneous abdominal adipose tissue (AT). We used microdialysis to study the in situ lipolytic effects of dobutamine (selective  1 -agonist) and terbutaline (selective  2 -agonist) on glycerol release (lipolytic index) in abdominal subcutaneous AT in 10 obese girls aged 13-17 years, BMI 38 ± 2.1 kg/m 2 , and in 7 lean girls aged 11-17 years, BMI 21 ± 1.1 kg/m 2 , and compared them with 10 obese women aged 21-39 years, BMI 36 ± 1.6 kg/m 2 , and 10 lean women aged 18-42 years, BMI 21 ± 0.4 kg/m 2 . Terbutaline at 10 -6 mol/l stimulated glycerol release more efficiently in lean girls than in obese girls (peak response ~350 vs. 150% of control, P < 0.01). At the lower concentration of agonist, no significant difference was seen. In women, terbutaline was more effective in lean than in obese women in stimulating glycerol release at both 10 -8 mol/l (peak response lean ~175% vs. obese 125% of control) and 10 -6 mol/l (~300 vs. 150% of control, P < 0.05). No significant difference in glycerol release between obese and lean girls or women was detected with selective  1 -stimulation. Our data demonstrate a specific impairment in the capacity of  2 -adrenergic agonists to promote lipolysis in subcutaneous abdominal adipose tissue of obese adolescent girls and women. Thus, decreased mobilization of fat during activation of the adrenergic system might be present early in the development of adolescent obesity. Diabetes 49:2149-2153, 2000 T he prevalence of obesity in children as well as in adults is steadily increasing in the U.S. (1). The early-onset type of obesity deserves special attention because youth-onset obesity is often the precursor of the most intractable form of adult obesity (2). Furthermore, the comorbid conditions that accompany obesity in adults, such as type 2 diabetes, dyslipidemia, and hypertension, are seen with increasing frequency in overweight adolescents and even preadolescents (3,4).Although the pathogenesis of obesity is poorly understood, it is believed to result from a complex interaction between genetic and environmental factors (5), leading to a more efficient accumulation of fat and to an impaired ability to mobilize fat. Because catecholamines are the only hormones with pronounced lipolytic action in humans (6), the effect of obesity in adults on the responsiveness to catecholamines has been extensively studied. Both in vitro and in vivo studies have demonstrated that subcutaneous abdominal adipose tissue in obese adults is resistant to the lipolytic effects of catecholamines (7-9). Moreover, even though subcutaneous adipose tissue contains  1 -,  2 -, and  3 -adrenoceptors, obesityinduced catecholamine resistance appears primarily because of defects in  2 -stimulation (7), with impaired  1 -stimulation having a secondary role. Whereas obese children have been shown to have a reduced lipolytic response to systemic epinephrine infusion (9), the effect of juvenile obesi...